Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
The European Journal of Health Economics
Erschienen in: The European Journal of Health Economics 6/2017

20.08.2016 | Original Paper

The costs of hazardous alcohol consumption in Germany

verfasst von: Tobias Effertz, Frank Verheyen, Roland Linder

Erschienen in: The European Journal of Health Economics | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Hazardous alcohol consumption in Germany is a main threat to health. By using insurance claim data from the German Statutory Health Insurance and a classification strategy based on ICD10 diagnoses-codes we analyzed a sample of 146,000 subjects with more than 19,000 hazardous alcohol consumers. Employing different regression models with a control function approach, we calculate life years lost due to alcohol consumption, annual direct and indirect health costs, and the burden of pain and suffering measured by the Charlson-Index and assessed pain diagnoses. Additionally, we simulate the net accumulated premium payments over expenses in the German Statutory Health Insurance and the Statutory Pension Fund for hazardous alcohol consumers from a lifecycle perspective. In total, €39.3 billion each year result from hazardous alcohol consumption with an average loss of 7 years in life expectancy. Hazardous alcohol consumers clearly do not "pay their way" in the two main German social security systems and also display a higher intangible burden according to our definitions of pain and suffering.
Anhänge
Nur mit Berechtigung zugänglich
Fußnoten
Literatur
1.
Anderson, P., Müller, L., Galea, G.: Alcohol in the European Union: Consumption, Harm and policy approaches. World Health Organization, Regional Office for Europe, Copenhagen (2012)
2.
3.
Dawson, D.A.: Measuring alcohol consumption: limitations and prospects for improvement. Addiction 93, 965–968 (1998)CrossRefPubMed
4.
Horch, K., Bergmann, E.: Berechnung der Kosten alkoholassoziierter Krankheiten. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 46, 625–635 (2003)CrossRef
5.
Konnopka, A., König, H.H.: Direct and indirect costs attributable to alcohol consumption in Germany. Pharmacoeconomics 25(7), 605–618 (2007)CrossRefPubMed
6.
Adams, M., Effertz, T.: Die volkswirtschaftlichen Kosten des Alkohol- und Nikotinkonsums. In: Singer, M.V., Batra, A., Mann, K. (eds.) Alkohol, Tabak und Folgeerkrankungen, pp. 57–62. Thieme Verlag, Stuttgart (2011)
7.
Rehm, J., Frick, U.: Moderater Alkoholkonsum. In: Singer, M.V., Batra, A., Mann, K. (eds.) Alkohol und Tabak—Grundlagen und Folgeerkrankungen, pp. 35–40. Thieme Verlag, Stuttgart (2010)
8.
Fillmore, K.M., Stockwell, T., Chikritzhs, T., Bostrom, A., Kerr, W.: Moderate alcohol use and reduced mortality risk: systematic error in prospective studies and new hypotheses. Ann. Epidemiol. 17, S16–S23 (2007)CrossRefPubMed
9.
Knott, C.S., Coombs, N., Stamatakis, E., Biddulph, J.P.: All cause mortality and the case for age specific alcohol consumption guidelines: pooled analyses of up to 10 population based cohorts. BMJ 350, h384 (2015)CrossRefPubMedPubMedCentral
10.
Pabst, A., Kraus, L., de Matos, E.G., Piontek, D.: Substanzkonsum und substanzbezogene Störungen in Deutschland im Jahr 2012. SUCHT 59(6), 321–331 (2013)CrossRef
11.
Pabst, A., Kraus, L., Piontek, D., Mueller, S.: Age, period, and cohort effects on time trends in alcohol consumption in the german adult population. Alters-, Perioden- und Kohorteneinflüsse auf Trends im Alkoholkonsum in der deutschen Allgemeinbevölkerung. SUCHT 56(5), 349–359 (2010)CrossRef
12.
Hingson, R.W., Heeren, T., Winter, M.R.: Age at drinking onset and alcohol dependence: age at onset, duration, and severity. Arch. Pediatr. Adolesc. Med. 160, 739–746 (2006)CrossRefPubMed
13.
Viner, R.M., Taylor, B.: Adult outcomes of binge drinking in adolescence: findings from a UK national birth cohort. J. Epidemiol. Community Health 61, 902–907 (2007)CrossRefPubMedPubMedCentral
14.
Singer, M., Batra, A., Mann, K.: Alkohol und Tabak: Grundlagen und Folgeerkrankungen. Thieme Verlag, Heidelberg, Stuttgart (2010)
15.
Forberger, S., Rehm, J.: Alkoholassozierte Krankheitslast in Deutschland. SuchtAktuell 1, 5–8 (2010)
16.
Schilling, E.A., Aseltine, R.H., Glanovsky, J.L., James, A., Jacobs, D.: Adolescent alcohol use, suicidal ideation, and suicide attempts. J. Adolesc. Health 44, 335–341 (2009)CrossRefPubMed
17.
Fergusson, D.M., Boden, J.M., Horwood, L.J.: Alcohol misuse and psychosocial outcomes in young adulthood: results from a longitudinal birth cohort studied to age 30. Drug Alcohol Depend. 133(2), 513–519 (2013)CrossRefPubMed
18.
Taylor, B., Rehm, J.: The relationship between alcohol consumption and fatal motor vehicle injury: high risk at low alcohol levels. Alcohol. Clin. Exp. Res. 36(10), 1827–1834 (2012)CrossRefPubMedPubMedCentral
19.
Effertz, T., Mann, K.: The burden and cost of disorders of the brain in Europe with the inclusion of harmful alcohol use and nicotine addiction. Eur. Neuropsychopharmacol. 23(7), 742–748 (2013)CrossRefPubMed
20.
Rehm, J., Rehm, M., Shield, K.D., Gmel. G., Frick, U., Mann, K.: Alkoholkonsum, Alkoholabhän- gigkeit und Gesundheitsschäden in Deutschland. Szenarien eines verbesserten Zugangs zur Behandlung der Alkoholabhängigkeit. Toronto, ON: Addiction and Mental Health/Dresden: Technische Universität Dresden (2012)
21.
22.
John, U., Rumpf, H.J., Bischof, G., Hapke, U., Hanke, M., Meyer, C.: excess mortality of alcohol-dependent individuals after 14 years and mortality predictors based on treatment participation and severity of alcohol dependence. Alcohol. Clin. Exp. Res. 37(1), 156–163 (2013)CrossRefPubMed
23.
Rice, D.P.: Estimating the cost of illness. Health economics series, 6. Department of Health Education and Welfare, Rockville (1966)
24.
Koopmanschap, M.A., Rutten, F.F.H., van Ineveld, B.M., van Roijen, L.: The friction cost method for measuring indirect costs of disease. J. Health Econ. 14, 171–189 (1995)CrossRefPubMed
25.
Charlson, M.E., Pompei, P., Ales, K.L., MacKenzie, C.R.: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chron. Dis. 40(5), 373–383 (1986)CrossRef
26.
Swart, E., Ihle, P.: Routinedaten im Gesundheitswesen. Handbuch Sekundärdatenanalyse: Grundlagen, Methoden und Perspektiven 2. Auflage. Huber 2014, Bern
27.
Wittchen, H.U., Behrendt, S., Höfler, M., Perkonigg, A., Lieb, R., Bühringer, G., Beesdo, K.: What are the high risk periods for incident substance use and transitions to abuse and dependence? Implications for early intervention and prevention. Int. J. Methods Psychiatr. Res. 17(S1), S16–S29 (2008)CrossRefPubMed
28.
Mullahy, J.: Specification and testing of some modified count data models. J. Econ. 33(3), 341–365 (1986)CrossRef
29.
Wooldridge, J.M.: Econometric analysis of cross section and panel data, 2nd edn. MIT Press, Cambridge, Massachusetts (2010)
30.
Angrist, J.D., Krueger, A.B.: Instrumental variables and the search for identification: from supply and demand to natural experiments. J. Econ. Perspect. 15(4), 69–85 (2001)CrossRef
31.
Hamdi, N.R., Krueger, R.F., South, S.C.: socioeconomic status moderates genetic and environmental effects on the amount of alcohol use. Alcohol. Clin. Exp. Res. 39, 603–610 (2015)CrossRefPubMedPubMedCentral
32.
Clark, D., Royer, H.: The Effect of education on adult mortality and health: evidence from Britain. Am. Econ. Rev. 103(6), 2087–2120 (2013)CrossRef
33.
Basu, A., Manning, W.G.: Estimating lifetime or episode-of-illness-costs under censoring. Health Econ. 19, 1010–1028 (2010)CrossRefPubMed
34.
Westman, J., Wahlbeck, K., Laursen, T.M., Gissler, M., Nordentoft, M., Hällgren, J., Arffman, M., Ösby, U.: Mortality and life expectancy of people with alcohol use disorder in Denmark, Finland and Sweden. Acta Psychiatr. Scand. 131, 297–306 (2015)CrossRefPubMed
35.
Roerecke, M., Rehm, J.: Alcohol use disorders and mortality: a systematic review and meta-analysis. Addiction 108, 1562–1578 (2013)CrossRefPubMed
36.
Grabs, J., Ishorst-Witte, F., Püschel, K.: Krank bin ich, wenn nichts mehr geht! Todesursachen wohnungsloser Menschen in Hamburg. In: Hamburger Ärzteblatt 5/2008, S. 6–8 (2008)
37.
Bell, H., Jahnsen, J., Kittang, E., Raknerud, N., Sandvik, L.: Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit. Scand. J. Gastroenterol. 39(9), 858–863 (2004)CrossRefPubMed
38.
Sandahl, T.D., Jepsen, P., Thomsen, K.L., Vilstrup, H.: Incidence and mortality of alcoholic hepatitis in Denmark 1999–2008: a nationwide population based cohort study. J. Hepatol. 54, 760–764 (2011)CrossRefPubMed
39.
Stokkeland, K., Brandt, L., Ekbom, A., Ösby, U., Hultcrantz, R.: Morbidity and mortality in liver diseases in Sweden 1969–2001 in relation to alcohol consumption. Scand. J. Gastroenterol. 41, 463–468 (2006)CrossRef
40.
Wittchen, H.U., et al.: The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur. Neuropsychopharmacol. 21, 655–679 (2011)CrossRefPubMed
41.
Effertz, T.: Die volkswirtschaftlichen Kosten gefährlicher Konsumgüter—Eine theoretische und empirische Analyse für Deutschland am Beispiel Alkohol, Tabak und Adipositas. Peter Lang Verlag; Frankfurt am Main, Bern (2015)
Metadaten
Titel
The costs of hazardous alcohol consumption in Germany
verfasst von
Tobias Effertz
Frank Verheyen
Roland Linder
Publikationsdatum
20.08.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
The European Journal of Health Economics / Ausgabe 6/2017
Print ISSN: 1618-7598
Elektronische ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-016-0822-1

Weitere Artikel der Ausgabe 6/2017

The European Journal of Health Economics 6/2017 Zur Ausgabe

Original Paper

Waist circumference, body mass index, and employment outcomes

Original Paper

Cost-effectiveness analysis of new generation coronary CT scanners for difficult-to-image patients

Editorial

The enigma of value: in search of affordable and accessible health care

Original Paper

Why do health technology assessment coverage recommendations for the same drugs differ across settings? Applying a mixed methods framework to systematically compare orphan drug decisions in four European countries

Original Paper

A comparison of average wages with age-specific wages for assessing indirect productivity losses: analytic simplicity versus analytic precision

Original Paper

China’s medical savings accounts: an analysis of the price elasticity of demand for health care